Search results
Showing 631 to 645 of 1363 results for social care
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
health inequalities Supporting the health and care system to implement virtual wards Social care General practice - keep...
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
Evidence-based recommendations on pegunigalsidase alfa (Elfabrio) for Fabry disease (also known as alpha-galactosidase deficiency) in adults.
International collaboration with NICE
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC
In development Reference number: GID-TA11023 Expected publication date: TBC
guidance"}}]} NICE guidance implementation toolkits To support health and care organisations in putting evidence-based recommendations...
Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTG676)
Early value assessment (EVA) guidance on digitally enabled therapies for adults with anxiety disorders.
Onasemnogene abeparvovec for treating spinal muscular atrophy (HST15)
Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies.
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
This guideline covers interventions to prevent sexually transmitted infections (STIs) in people aged 16 and over. It aims to reduce the transmission of all STIs, including HIV, and includes ways to help increase the uptake of STI testing and vaccines for human papillomavirus (HPV) and hepatitis A and B.
This guideline covers needle and syringe programmes for people (including those under 16) who inject drugs. The main aim is to reduce the transmission of viruses and other infections caused by sharing injecting equipment, such as HIV, hepatitis B and C. In turn, this will reduce the prevalence of blood-borne viruses and bacterial infections, so benefiting wider society.
This guide provides an overview of the principles and methods of health technology assessment and appraisal within the context of the NICE appraisal process